Monsanto v. Durnell · ¶56

As Riegel indicates, allowing Durnell’s state tort claim to overcome preemption would affect more than FIFRA. The Medical Device Amendments and several other federal statutes across a range of industries contain similar or identical labeling preemption provisions. See, e.g., 21 U. S. C. §§678; 1052(b); 467e; 379s(a), 379r(a)(2); 343– 1(a)(2)–(4). Those similar labeling preemption clauses reflect Congress’s judgment that the ability to sell a product throughout the country with a single label can be important to maintaining an efficient nationwide market.

slip opinion
Source edition
Passage preview. Read in context for the complete text, notes and references.